AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,870,000 | -48.4% | 139,132 | -21.2% | 0.07% | -48.3% |
| Q2 2020 | $9,439,000 | +184.4% | 176,491 | +88.7% | 0.14% | +116.7% |
| Q1 2020 | $3,319,000 | +38.5% | 93,552 | +86.4% | 0.07% | +106.2% |
| Q4 2019 | $2,397,000 | -6.1% | 50,190 | -36.3% | 0.03% | -13.5% |
| Q3 2019 | $2,552,000 | -75.8% | 78,751 | -62.8% | 0.04% | -72.8% |
| Q2 2019 | $10,556,000 | -0.4% | 211,619 | +34.7% | 0.14% | -2.9% |
| Q1 2019 | $10,596,000 | +181.2% | 157,118 | +92.3% | 0.14% | +154.5% |
| Q4 2018 | $3,768,000 | – | 81,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |